- CA$749.96m
- CA$2.51bn
- CA$386.95m
- 49
- 76
- 71
- 71
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 580 | 348 | 326 | 344 | 387 |
Cost of Revenue | |||||
Gross Profit | 364 | 105 | 91.1 | 114 | 125 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 282 | 292 | 281 | 298 | 332 |
Operating Profit | 299 | 55.6 | 45.1 | 45.6 | 54.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 440 | 198 | 126 | 197 | -120 |
Provision for Income Taxes | |||||
Net Income After Taxes | 332 | 160 | 111 | 164 | -117 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 332 | 159 | 110 | 164 | -117 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 334 | 159 | 110 | 164 | -117 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.38 | 3.25 | 2.41 | 2.09 | -2.66 |
Dividends per Share | |||||
Special Dividends per Share |